Neural Stem Cell Research Lab (@NSCRLab) header
Neural Stem Cell Research Lab (@NSCRLab) profile picture

🧠 Modelling neurodegenerative diseases šŸ’¼ Job openings National Neuroscience Institute

Singapore
Joined August 2022
Photo by Neural Stem Cell Research Lab (@NSCRLab)Photo by Neural Stem Cell Research Lab (@NSCRLab)
Our lab is at the #ADPD2023!! First physical international conference in 3 years! @adpdnet
1
109
Check out our latest study on the effects of itanapraced on #Parkinsons disease! Thanks @mnt for the feature šŸ‘šŸ¼
Alzheimer’s drug candidate may have potential for treating Parkinson’s disease zpr.io/yMKhmUe6ZXhW #ScienceTwitter
Upcoming ⁦ @devbio_sg virtual ⁩seminar by Associate Professor Quenten Schwarz on interneuron development, happening on 27 October! ⁦ @phil1pingham @MonteiroLab @onsunlau_nus @NSCRLab @HongyanWang9 @Yusuke_Toyama @ReversadeLab @unisaresearch
5
6
Upcoming exciting ⁦@devbio_sg⁩ seminar by Anna Akhmanova on #microtubules! ⁦@phil1pingham⁩ ⁦@MonteiroLab⁩ ⁦@onsunlau_nus⁩ ⁦@NSCRLab⁩ @HongyanWang9⁩ ⁦@Yusuke_Toyama⁩ ⁦@ReversadeLab⁩
7
10
Neural Stem Cell Research Lab retweeted
SCSS Symposium 2022: Registration is open - mailchi.mp/d04991d7e09c/scss…
Thanks for the feature! @Ingentium_PD The APP intracellular domain promotes LRRK2 expression to enable feed-forward neurodegenerative mechanisms in Parkinson's disease. magazine.ingentium.com/2022/…
Neural Stem Cell Research Lab retweeted
An experimental therapy for Alzheimer’s disease can break a molecular loop and protect neurons in mouse models of Parkinson’s disease, hinting similar approaches could prove beneficial for this incurable neurodegenerative condition. @NSCRLab #Neuroscience fcld.ly/2ro163e
Neural Stem Cell Research Lab retweeted
Annovis Bio @AnnovisBio has announced that the 1st patient in the Phase 3 clinical trial evaluating buntanetap (aka ANVS401, Posiphen) in early stage #Parkinsons has been dosed; The trial will enroll a total of 450 participants, treatment for 6 months irpages2.eqs.com/websites/an…
1
2
7
We propose that AICD cooperates with transcription factor of FOXO3a to promote LRRK2 transcriptional activation and expression. Experimental drug, itanapraced, inhibits LRRK2-mediated neurotoxicity. @ScienceMagazine @scisignal #Parkinsonsdisease
1
3
Neural Stem Cell Research Lab retweeted
An experimental treatment for Alzheimer’s disease can break a molecular loop and protect neurons in mouse models of #ParkinsonsDisease, suggesting similar approaches could prove beneficial for this incurable neurodegenerative condition. fcld.ly/j7bul55 @SciSignal
2
18
1
66
Neural Stem Cell Research Lab retweeted
A positive feedback loop between AICD and #LRRK2 drives #neurodegeneration and mitochondrial dysfunction in #ParkinsonsDisease but can be targeted with the experimental drug itanapraced, show experiments in mice from the Tan and Zeng labs. @mysgh @NSCRLab fcld.ly/ccrcssg
2
5
Neural Stem Cell Research Lab retweeted
New paper from the @NSCRLab! They found that in cultured neurons & brain tissue from mouse models of #ParkinsonsDisease, LRRK2-mediated phosphorylation of APP increased the abundance and activity of the APP intracellular domain. 🧠 @scisignal https://xitter.cf/t.co/uZwqFKFCNG
2
2
Neural Stem Cell Research Lab retweeted
A self-sustaining molecular loop that drives Parkinson’s disease can be targeted in mice, new research answers a longstanding question about Wnt signaling, and more in this week’s new issue of Science Signaling. fcld.ly/q53lnia
1
6
36
Congrats to Vivek on his publication in Biomaterials Science in his discovery on recapitulating the spontaneous enhancement of pathogenic amyloid-beta 42 and pTau levels in differentiated neurons carrying familial AD (FAD) mutations on microfiber scaffold-based 3D culture model.
1
Our collaborative study with Robin's lab in A*Star is now up in Stem Cell Research and Therapy! We have shown value of in vivo functional imaging for the assessment of cell therapies i.e. determination of early post-transplant cell maturation and differentiation of hESC-mDAs.
1